FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndTotal liabilities (Million JPY)YoY (%)
Mar 31, 20253,239-30.84%
Mar 31, 20244,683+14.36%
Mar 31, 20234,095-23.94%
Mar 31, 20225,384-26.23%
Mar 31, 20217,299+2.06%
Mar 31, 20207,151-18.92%
Mar 31, 20198,821-13.74%
Mar 31, 201810,225-8.21%
Mar 31, 201711,140+34.82%
Mar 31, 20168,263+241.31%
Mar 31, 20152,421
AI Chat